Article
The FDA announced that it granted two additional approvals to Syneron Medical Ltd. and its North American subsidiary, Syneron Inc., for the company's hair removal and skin rejuvenation devices.
Innovating Scalp Care: How Research and Education Drive Solutions
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Role of Zinc, Copper, and Vitamin D in Alopecia Areata Explored
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
QRX003 Shows Promise in Pediatric Patients with Netherton Syndrome, Quoin Announces
High-Risk CSCC Trial Validates Cemiplimab's Potential